{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:10Z","timestamp":1772119390655,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Center Research and Development Funds","award":["23-A-16"],"award-info":[{"award-number":["23-A-16"]}]},{"name":"National Cancer Center Research and Development Funds","award":["23-A-18"],"award-info":[{"award-number":["23-A-18"]}]},{"name":"National Cancer Center Research and Development Funds","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}]},{"name":"National Cancer Center Research and Development Funds","award":["29-A-3"],"award-info":[{"award-number":["29-A-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10147-023-02464-1","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T05:02:10Z","timestamp":1707195730000},"page":"248-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system"],"prefix":"10.1007","volume":"29","author":[{"given":"Kotaro","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiju","family":"Aokage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Kaminuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokiko","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Tane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"2464_CR1","unstructured":"Ferlay J EM, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2020) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. https:\/\/gco.iarc.fr\/today. Accessed 24, August 2022"},{"key":"2464_CR2","unstructured":"Ettinger DS, Wood DE, Aisner DL (2022) NCCN Guidelines Version 3.2022 Non-Small Cell Lung Cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed 24 August 2022"},{"issue":"21","key":"2464_CR3","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/jco.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV et al (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26(21):3552\u20133559. https:\/\/doi.org\/10.1200\/jco.2007.13.9030","journal-title":"J Clin Oncol"},{"issue":"22","key":"2464_CR4","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1200\/jco.2013.50.1049","volume":"32","author":"JJ Hung","year":"2014","unstructured":"Hung JJ, Yeh YC, Jeng WJ et al (2014) Predictive value of the international association for the study of lung cancer\/American Thoracic Society\/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol 32(22):2357\u20132364. https:\/\/doi.org\/10.1200\/jco.2013.50.1049","journal-title":"J Clin Oncol"},{"issue":"12","key":"2464_CR5","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/JTO.0b013e31818e0d9f","volume":"3","author":"WD Travis","year":"2008","unstructured":"Travis WD, Brambilla E, Rami-Porta R et al (2008) Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 3(12):1384\u20131390. https:\/\/doi.org\/10.1097\/JTO.0b013e31818e0d9f","journal-title":"J Thorac Oncol"},{"issue":"7","key":"2464_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/JTO.0b013e3182519a42","volume":"7","author":"KA Higgins","year":"2012","unstructured":"Higgins KA, Chino JP, Ready N et al (2012) Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. J Thorac Oncol 7(7):1141\u20131147. https:\/\/doi.org\/10.1097\/JTO.0b013e3182519a42","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2464_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/jto.0000000000000486","volume":"10","author":"K Kadota","year":"2015","unstructured":"Kadota K, Nitadori JI, Sima CS et al (2015) Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I Lung adenocarcinomas. J Thorac Oncol 10(5):806\u2013814. https:\/\/doi.org\/10.1097\/jto.0000000000000486","journal-title":"J Thorac Oncol"},{"key":"2464_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.lungcan.2021.07.001","volume":"159","author":"H Oiwa","year":"2021","unstructured":"Oiwa H, Aokage K, Suzuki A et al (2021) Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis. Lung Cancer 159:74\u201383. https:\/\/doi.org\/10.1016\/j.lungcan.2021.07.001","journal-title":"Lung Cancer"},{"issue":"2","key":"2464_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.humpath.2013.10.011","volume":"45","author":"AL Moreira","year":"2014","unstructured":"Moreira AL, Joubert P, Downey RJ et al (2014) Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol 45(2):213\u2013220. https:\/\/doi.org\/10.1016\/j.humpath.2013.10.011","journal-title":"Hum Pathol"},{"issue":"1","key":"2464_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ajcp\/aqy032","volume":"150","author":"M Kuang","year":"2018","unstructured":"Kuang M, Shen X, Yuan C et al (2018) Clinical significance of complex glandular patterns in lung adenocarcinoma: clinicopathologic and molecular study in a large series of cases. Am J Clin Pathol 150(1):65\u201373. https:\/\/doi.org\/10.1093\/ajcp\/aqy032","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"2464_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira AL, Ocampo PSS, Xia Y et al (2020) A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol 15(10):1599\u20131610. https:\/\/doi.org\/10.1016\/j.jtho.2020.06.001","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2464_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/jto.0000000000000516","volume":"10","author":"LM Sholl","year":"2015","unstructured":"Sholl LM, Aisner DL, Varella-Garcia M et al (2015) Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: the Lung Cancer Mutation Consortium Experience. J Thorac Oncol 10(5):768\u2013777. https:\/\/doi.org\/10.1097\/jto.0000000000000516","journal-title":"J Thorac Oncol"},{"key":"2464_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lungcan.2021.07.018","volume":"160","author":"K Aokage","year":"2021","unstructured":"Aokage K, Miyoshi T, Wakabayashi M et al (2021) Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinoma. Lung Cancer 160:8\u201316. https:\/\/doi.org\/10.1016\/j.lungcan.2021.07.018","journal-title":"Lung Cancer"},{"issue":"5","key":"2464_CR14","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jtcvs.2017.06.062","volume":"154","author":"K Takamochi","year":"2017","unstructured":"Takamochi K, Oh S, Matsunaga T et al (2017) Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma. J Thorac Cardiovasc Surg 154(5):1768-1774.e1761. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.06.062","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2464_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D et al (2020) Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med 382(1):41\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1913662","journal-title":"N Engl J Med"},{"issue":"18","key":"2464_CR16","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","volume":"383","author":"YL Wu","year":"2020","unstructured":"Wu YL, Tsuboi M, He J et al (2020) Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med 383(18):1711\u20131723. https:\/\/doi.org\/10.1056\/NEJMoa2027071","journal-title":"N Engl J Med"},{"key":"2464_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2023.02.002","author":"Y Tsutani","year":"2023","unstructured":"Tsutani Y, Goldman JW, Dacic S et al (2023) Adjuvant osimertinib vs. placebo in completely resected stage IA2-IA3 EGFR-mutated NSCLC: ADAURA2. Clin Lung Cancer. https:\/\/doi.org\/10.1016\/j.cllc.2023.02.002","journal-title":"Clin Lung Cancer"},{"key":"2464_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.xjon.2020.08.009","volume":"4","author":"H Kunitoh","year":"2020","unstructured":"Kunitoh H, Tsuboi M, Wakabayashi M et al (2020) A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707). JTCVS Open 4:90\u2013102. https:\/\/doi.org\/10.1016\/j.xjon.2020.08.009","journal-title":"JTCVS Open"},{"issue":"2","key":"2464_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/jto.0000000000000069","volume":"9","author":"DY Shin","year":"2014","unstructured":"Shin DY, Na II, Kim CH et al (2014) EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol 9(2):195\u2013199. https:\/\/doi.org\/10.1097\/jto.0000000000000069","journal-title":"J Thorac Oncol"},{"key":"2464_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lungcan.2016.04.004","volume":"96","author":"F Hsu","year":"2016","unstructured":"Hsu F, De Caluwe A, Anderson D et al (2016) EGFR mutation status on brain metastases from non-small cell lung cancer. Lung Cancer 96:101\u2013107. https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.004","journal-title":"Lung Cancer"},{"issue":"1","key":"2464_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","volume":"111","author":"K Suda","year":"2021","unstructured":"Suda K, Mitsudomi T, Shintani Y et al (2021) Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases. Ann Thorac Surg 111(1):269\u2013276. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.05.041","journal-title":"Ann Thorac Surg"},{"key":"2464_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lungcan.2018.12.027","volume":"129","author":"B Yang","year":"2019","unstructured":"Yang B, Lee H, Um SW et al (2019) Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis on the basis of stage and genetic alterations. Lung Cancer 129:28\u201334. https:\/\/doi.org\/10.1016\/j.lungcan.2018.12.027","journal-title":"Lung Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02464-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:10:55Z","timestamp":1708575055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02464-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3188973\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}